Search

everythinglearnresearchcommunity

for

Search:↓

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Most patients improved with oral contraceptives, but some needed additional treatment.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Birth control pills can help reduce mild to moderate acne in women.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.